M&A Deal Summary

Symrise Acquires Therapeutic Peptides

On August 19, 2008, Symrise acquired life science company Therapeutic Peptides

Acquisition Highlights
  • This is Symrise’s 1st transaction in the Life Science sector.
  • This is Symrise’s 1st transaction in the United States.
  • This is Symrise’s 1st transaction in Louisiana.

M&A Deal Summary
Date 2008-08-19
Target Therapeutic Peptides
Sector Life Science
Buyer(s) Symrise
Deal Type Add-on Acquisition

Target

Therapeutic Peptides

Baton Rouge, Louisiana, United States
TPI specializes in the development and production of anti-microbial and anti-aging ingredients known as Peptides. Peptides are popular, effective ingredients increasingly used in modern cosmetic products.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Symrise

Holzminden, Germany
Category Company
Founded 1874
Sector Chemicals
Employees12,656
Revenue 4.7B EUR (2023)
DESCRIPTION

Symrise is a producer of flavours, fragrances, cosmetic ingredients and aroma chemicals in the world. Symrise was founded in 1874 and is based in Holzminden, Germany.

DEAL STATS #
Overall 1 of 14
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 10
State (Louisiana) 1 of 1
Country (United States) 1 of 8
Year (2008) 1 of 3
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-25 J.Manheimer

Teterboro, New Jersey, United States

J.Manheimer, Inc. provides fragrance and essential oils for personal care, air care, home care, and automotive products.

Buy -
Mergr

Product

Company

Legal